Get started
Author

Jana L. Gump

ABCG2 expression, function, and promoter methylation in human multiple myeloma
2006 · Joel G. Turner, Jana L. Gump, et al. · Blood · 189
Histone deacetylase interacts directly with DNA topoisomerase II
2000 · Shih-Chang Tsai, Nikola Valkov, et al. · Nature Genetics · 145
Reconstruction of mandibular defects in irradiated patients
1990 · Douglas W. Klotch, Jana Gump, et al. · The American Journal of Surgery · 49
The cytoplasmic trafficking of DNA topoisomerase IIα correlates with etoposide resistance in human myeloma cells
2004 · Roxane Engel, Nikola I Valkov, et al. · Experimental Cell Research · 34
Effects of wild-type p53 expression on the quantity and activity of topoisomerase II? and ? in various human cancer cell lines
1999 · Daniel Hochhauser, Nikola I. Valkov, et al. · Journal of Cellular Biochemistry · 18
Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response
2008 · Stacy Moulder, Nickola Valkov, et al. · Cancer · 15
PDF
Quantitative immunofluorescence and immunoelectron microscopy of the topoisomerase IIα associated with nuclear matrices from wild-type and drug-resistant Chinese hamster ovary cell lines
1997 · Nikola I. Valkov, Jana L. Gump, et al. · Journal of Cellular Biochemistry · 15
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial
2006 · George R. Simon, Richard M. Lush, et al. · Molecular Cancer Therapeutics · 4
A single arm phase II trial of gemcitabine (G) and irinotecan (I) in metastatic breast cancer: Can localization of topoisomerase I (topo I) predict response to topo I inhibitors?
2006 · S. L. Moulder, N. Valkov, et al. · Journal of Clinical Oncology · 2
A phase i study of high-dose melphalan + topotecan + VP-16 phosphate (Mtv) Followed by autologous stem cell rescue in multiple myeloma
2000 · D. Sullivan, W. Dalton, et al. · Experimental Hematology · 2
Valproic acid sensitizes human melanoma cells to karenitecin in vitro and in vivo
2006 · Jana Gump, Douglas C. Marchion, et al. · Cancer Research · 1
Is cytoplasmic localization of topoisomerase I (topo I) a mechanism of resistance for topo I inhibitors? Results from an NCCN sponsored phase II trial of gemcitabine and irinotecan in metastatic breast cancer.
2006 · Stacy Moulder, Nikola Valkov, et al. · Cancer Research · 1
Nuclear and cytoplasmic topoisomerase II alpha are differentially phosphorylated and nuclear export is blocked by CRM1 antisense oligonucleotides
2005 · Joel G. Turner, Jana Gump, et al. · Cancer Research · 1
Blocking a Topoisomerase IIα Nuclear Export Signal Sensitizes Human Multiple Myeloma Cells to Topoisomerase II Inhibitors.
2009 · Joel G. Turner, Thomas C. Rowe, et al. · Blood
Phase I/II Trial of High-Dose Melphalan (M) and Topotecan (T) Followed by Autologous Stem Cell Rescue in Patients ≤ 60 and > 60 Years of Age with Multiple Myeloma (MM).
2007 · Daniel Sullivan, Melissa Alsina, et al. · Blood
293 POSTER Phase I trial of the histone deacetylase inhibitor valproic acid with the topoisomerase I inhibitor, karenitecin in advanced melanoma
2006 · A. Daud, J.L. Gump, et al. · European Journal of Cancer Supplements
Works count: 16
Citation count: 476
H-index: 7
I10-index: 7
Year
Topic
Type